How to Verify a GLP-1 Telehealth Provider Is Legitimate: A Safety Checklist for 2026

The demand for GLP-1 weight loss medications — including Wegovy (semaglutide) and Zepbound (tirzepatide) — has exploded in recent years, and so has the number of providers, websites, and med spas claiming to offer them. A June 2026 CBS News investigation found hundreds of websites openly advertising counterfeit and improperly compounded GLP-1 drugs, many without proper licensing or medical oversight.

If you are looking for GLP-1 treatment through telehealth, knowing how to verify that a provider is legitimate could protect your health — and your wallet.

Why This Matters: The Compounded GLP-1 Problem

During the Wegovy and Ozempic drug shortages of 2023–2024, the FDA temporarily allowed 503A and 503B compounding pharmacies to legally produce compounded versions of semaglutide. As the shortages resolved, the FDA moved to restrict compounded semaglutide — though liraglutide (the active ingredient in Saxenda and Victoza) remains on the FDA Drug Shortage List as of June 2026, meaning compounded liraglutide may still be legally dispensed by qualified pharmacies.

The problem is that many websites and med spas continue to sell compounded semaglutide or tirzepatide without proper oversight, using unapproved formulations, incorrect dosing, or ingredients sourced outside of FDA-regulated supply chains. In some cases, these products contain no active ingredient at all.

The stakes are not trivial. GLP-1 medications are injectable drugs that affect your metabolism, cardiovascular system, and gastrointestinal function. Getting them from an unverified source carries real clinical risk.

The Legitimate GLP-1 Telehealth Provider Checklist

Use this checklist before booking with any telehealth platform that offers GLP-1 prescriptions:

1. The Provider Is Licensed in Your State

Every licensed prescriber in the United States must hold an active medical license in the state where you (the patient) are located at the time of the visit. This is a legal requirement for telehealth prescribing in all 50 states.

How to verify: Most states have an online license verification tool through their state medical board. Search "[your state] medical board license lookup" and enter the provider's name or license number.

Red flag: A website that does not identify the specific prescriber you will be seeing, or does not require you to confirm your state of residence before booking.

2. The Provider Has a DEA Registration (If Prescribing Controlled Substances)

GLP-1 medications themselves are not controlled substances. However, if a provider is offering ADHD treatment or other controlled substance prescribing alongside GLP-1 services, they must hold a valid DEA registration.

How to verify: Use the DEA Diversion Control Division's online registration check at deadiversion.usdoj.gov.

Note: DEA registration is not required to prescribe GLP-1 medications, but its presence signals a fully credentialed and federally registered practice.

3. The Platform Has LegitScript Certification (or Equivalent)

LegitScript is an independent organization that verifies that online pharmacies and healthcare platforms comply with applicable laws and industry standards. Look for LegitScript certification — or ask the platform directly whether they have undergone third-party compliance review.

Why it matters: Legitimate telehealth platforms that sell or prescribe medications are subject to LegitScript (or equivalent) review as a condition of running ads on Google and Meta. Unlicensed operators cannot obtain LegitScript certification and therefore typically cannot advertise through major channels — they rely on SEO spam, social media influencers, and word of mouth instead.

4. Prescriptions Are Filled at a Licensed U.S. Pharmacy

Your GLP-1 prescription should be sent to a licensed U.S. pharmacy — either a major retail chain (Walgreens, CVS, Walmart, Kroger) or a state-licensed compounding pharmacy registered with the FDA.

Red flags:

• Medication ships directly from the website with no pharmacy dispensing it
• Medication ships from outside the United States
• No NPI (National Provider Identifier) or pharmacy license number is provided
• You are asked to pay outside the normal prescription fulfillment process

You can verify U.S. pharmacy licensing through the National Association of Boards of Pharmacy (NABP) at nabp.pharmacy.

5. A Licensed Provider Conducts a Real Clinical Evaluation

A legitimate GLP-1 telehealth visit should involve a real clinical encounter — not just a brief online questionnaire where you self-select into a medication. Your provider should:

• Collect your medical history, including cardiovascular history (GLP-1s carry a black box warning related to thyroid C-cell tumors in patients with a personal or family history of MEN2 or medullary thyroid carcinoma)
• Review current medications for potential interactions
• Discuss your BMI, weight history, and any obesity-related comorbidities
• Explain the medication, expected timeline for results, common side effects, and when to seek urgent care

Red flag: A platform that asks you to fill out a short symptom checklist and approves your prescription within minutes, with no synchronous (real-time) provider interaction.

6. Pricing Is Transparent and There Are No Hidden Subscription Traps

Legitimate GLP-1 telehealth platforms are upfront about their full cost structure, including:

• The cost of the provider visit (or whether it is bundled with the medication)
• The cost of the medication itself, whether brand-name or compounded
• Any monthly membership or subscription fee
• Whether you can cancel without penalty

Red flag: "First month free" or deep discount offers followed by high recurring charges. Several compounding-focused GLP-1 platforms have drawn consumer complaints for difficult cancellation processes and surprise charges.

7. The Platform Is Clear About What It Is Prescribing

Due to the FDA crackdown on compounded semaglutide, any platform currently prescribing "semaglutide" at a price significantly below brand-name Wegovy pricing ($1,300+/month without insurance) should be transparent about the source and regulatory status of the compounded medication.

Ask directly:

• Is this FDA-approved brand-name semaglutide, or a compounded formulation?
• If compounded, what pharmacy is producing it, and is that pharmacy 503A or 503B registered?
• Is the compounded medication currently on the FDA's permitted shortage list?

A legitimate provider will answer these questions directly. Evasion is a red flag.

What to Look for in a Trustworthy GLP-1 Telehealth Platform

How Klarity Approaches GLP-1 Safety

At Klarity Health, every GLP-1 consultation is conducted by a licensed physician or nurse practitioner who is credentialed in your state and identified by name before you book. Prescriptions are sent to licensed U.S. pharmacies, and our providers conduct thorough clinical evaluations — not just a symptom checklist.

Our 2,000+ provider network includes practitioners experienced in weight management who can walk you through your insurance options, including the new Medicare GLP-1 Bridge program (for eligible Part D beneficiaries), manufacturer savings programs, and transparent self-pay pricing.

See if you may qualify for GLP-1 treatment through a licensed Klarity provider. Verify your coverage and get started

This article is for informational purposes only and does not constitute medical advice. GLP-1 medications require a prescription from a licensed healthcare provider and should be used under ongoing medical supervision. Always verify the credentials of any healthcare provider before beginning treatment.